跳至主要内容
临床试验/NCT04613141
NCT04613141已完成不适用

A Phase II Randomised Controlled Trial Comparing Home-based Self-managed Rehabilitation Program Using eHealth Technologies (Called WalkingTall-PD) With a Low-intensity Exercise Program (Called Mobility-plus).

Neuroscience Research Australia1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2021年7月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
62
试验地点
1
主要终点
Gait variability (immediate effect of stimulation)

研究概览

简要总结

The purpose of this study is to determine and compare the effectiveness of WalkingTall-PD (the new intervention) against Mobility-plus (a PD appropriate exercise program) with respect to stabilizing gait, reducing step-time variability, preventing falls and enhancing independence in people with Parkinson's disease.

WalkingTall-PD is a novel neuro-rehabilitation program delivered through a tablet/smart phone and smart socks for people with Parkinson's disease that aims to improve mobility and reduce falls. WalkingTall-PD combines a variety of PD-specific rhythmic stimuli (auditory, visual and haptic cues) which are synchronised with high intensity stepping, walking and balance training.

Mobility-plus is a "pseudo placebo" comparator program using non-slip socks, a low intensity paper-based exercise program and health information specific to Parkinson's Disease.

详细描述

WalkingTall-PD is designed to rehabilitate gait and balance in a minimum of 6-weeks (program progression and total duration is based on sessions completed). It uses affordable eHealth technologies (tablet, phone, smart socks or leg bands, depending on participant preference, with vibration motors, step mat and earbuds). Specific to Parkinson's disease (PD), it uses rhythmic cues to address excessive step-time variability, balance impairments and freezing of gait (FOG) (Henderson et al., 2017; Allen et al., 2013). The key aspect of this intervention is the stimulation provided by the smart socks/leg bands that vibrate. The stimulus duty cycle is synchronised with the participants walking gait to entrain neuromuscular signals and enhance sensorimotor integration. This results in an immediate improvement in motor control during gait, reduced movement variability and increased walking ability. The integration of our eHealth tools with home visits and telehealth appointments into a continuous user experience is another major strength of our program. Each component is introduced during 1:1 home visits and/or telehealth appointments to ensure standardization of the clinical trial and maximize the safety of participants. The home visits and/or telehealth appointments will be conducted by a trainer (physiotherapist or exercise physiologist with experience in working with people with PD).

WalkingTall-PD meets the urgent need for an effective, affordable and scalable self-managed eHealth solution for people with PD. It includes an evidence-based program to enhance independence and prevent falls. The scientific rationale and eHealth technology underpinning WalkingTall-PD are well tested. Our team has demonstrated that home-based approaches have high acceptability and adherence rates, shown that balance training can reduce fall-risk and that external cues can reduce step-time variability in people with PD. Participants may use their preferred devices (or devices we supply) to access WalkingTall-PD, which will be available across platforms. Components are introduced during 1:1 home visits and telehealth appointments by a trainer. Delivery is then unsupervised using self-management principles, with ongoing remote monitoring a web-based central monitoring platform and database back-end.Participants will be informed that WalkingTall-PD is a supplementary program and does not replace usual care. The WalkingTall-PD program comprises the following components:

(i) Balance training is introduced in the week-one home visit or telehealth appointment by the trainer using the WalkingTall smart phone app. Baseline balance ability is determined by completing a series of balance exercises using the app with supervision from the trainer. For participants who choose the telehealth option, the primary device (smart phone) will provide the training program while a secondary device (iPad) will be used for patient safety monitoring and telehealth consultation. Exercises include heel raises, postural transitions, reaching and stepping in different directions and holding poses that challenge balance. Props used include a mobile stand (primary device), a tablet stand for the secondary device, non-slip balance mat and chairs for support. Balance training starts with simple movement sequences and progresses to more challenging balance poses based on participant feedback. Movements during balance training are guided by the combination of haptic cues provided by the smart socks, insoles or ankle bands(with the choice of smart garment based on participant preference), auditory cues by the phone app and visual cues by the balance/stepping mat. Participants will be encouraged to complete 5 by 10-minutes balance training sessions/week. Participants who choose the telehealth option will be provided with a home visit if they have difficulty with the balance training.

(ii) Walk training (in a safe environment) is introduced in the second home visit or telehealth appointment (no sooner than week-3) by the trainer using our WalkingTall phone app. Participant-adjustable rhythmic cues (Brodie et al., 2015) auditory, visual and haptic cues are used to reduce gait variability during gait training. Participants are instructed how to select an appropriate walking course (clear of trip hazards and with appropriate rest areas), target cadence and training/rest duration by the trainer. The walking course will be approved by the trainers, either in person or remotely via video recording if the participant chooses the telehealth option. For participants included in the telehealth option, if the trainer has concerns about the selected walking track, a home visit will be provided to fix any safety issues. Each session, consists of 5 by 2-minutes walks with 30-seconds rest between each walk. Rhythmic auditory cues (self-selected metronome) are provided by the phone app and earbuds can be used for discretion. Rhythmic haptic cues are provided by the smart socks, insoles or smart ankle bands, with the choice of smart garment based on participant preference. Participant-specific visual cues may also be used, if required, such as parallel lines fixed perpendicular to the walking track to step over. Participants will be instructed to use their normal walking aids as appropriate. Participants will be encouraged to complete 5 by 10-minute walk training in addition to the 5 by 10-minute balance training sessions each week. Participants who choose the telehealth option will be provided with a home visit if they have difficulty with the walk training.

(iii) Step training is introduced in the third home visit or telehealth appointment (no sooner than week-5) by the trainer using the WalkingTall phone app. Visual, auditory and haptic cues are synchronized with the movement to retrain impaired stepping (Caetano et al., 2018), turning, balance (Allen et al., 2013) and strength in people with PD. Auditory stepping cues are provided by the phone app using a metronome beat. Visual cues are provided by the non-slip stepping mat. Haptic stepping cues are provided by small vibrators. Participants will be encouraged to complete 5 by 10-minute step/strength training, 5 by 10-minute walk training and 5 by 10-minute balance training sessions each week. In week-5 the trainer will also introduce walk training in more complex environments or walking as part of normal daily-life activities as appropriate. Participants who choose the telehealth option will be provided with a home visit if they have difficulty with the step and training.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

盲法说明

Assessments that occur after baseline randomization will be completed by blinded assessor. Excluding the immediate effect of stimulation on step time variability, which is impossible to blind as the participant using a stimulation device, which is not practical to conceal.

Statistician blinded.

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Have been diagnosed with idiopathic Parkinson's disease (according to UK PD Society Brain Bank Criteria);
  • •Mild to severe (Hoehn and Yahr stage 1-4 idiopathic Parkinson's disease;
  • •Ability to walk 18 meters with or without an aid;
  • •At least one fall in the past 6 months, or at least 2 falls in the past 12 months, or severe mobility impairment such as freezing of gait, or history of near falls.
  • •Being stable on anti-Parkinsonian medications for > 1 month;
  • •Living independently in the community or retirement village;
  • •Able to communicate in English language.

排除标准

  • •Diagnosis of other neurological and/ or significant cognitive impairments (Montreal Cognitive Assessment < 19 points);
  • •Atypical Parkinsonism;
  • •Less than 6 months post deep brain stimulation surgery;
  • •Excessively high fall rates (> 12 falls in the past 6 months);
  • •Insufficient foot/ ankle sensation;
  • •Do not speak English;
  • •Have another medical condition besides Parkinson's disease that significantly impairs mobility, balance or ability to exercise safely;
  • •Already participating in a different study to improve mobility or prevent falls.

研究组 & 干预措施

Mobility-plus

Sham Comparator

Mobility-plus is a "pseudo placebo" comparator program using non-slip socks, a low intensity paper-based exercise program and health information specific to Parkinson's Disease.

干预措施: Mobility-plus (Other)

WalkingTall-PD

Experimental

WalkingTall-PD is a novel neuro-rehabilitation program delivered through a tablet/smart phone and smart garments (socks, insoles or ankle bands) for people with Parkinson's disease that aims to improve mobility and reduce falls. WalkingTall-PD combines a variety of PD-specific rhythmic stimuli (auditory, visual and haptic cues) which are synchronised with high intensity stepping, walking and balance training.

干预措施: WalkingTall-PD (Device)

结局指标

主要结局

Gait variability (immediate effect of stimulation)

时间窗: Baseline and 3-month re-assessment

Standard deviation of step times will be assessed by a wearable device (McRoberts). This will be measured for both face-to-face and telehealth options. Baseline walking is compared to baseline walking with simulation (for the intervention group) and compared to walking with non-slip socks (for the control group). This will be repeated at 3-months. For face to face, gait variability will be assessed using the middle 16m of 4 x 20m straight line walks. For telehealth, it may not be possible to find a 20m straight line walking track, in which case more laps will be required to get a total distance of at least 80 meters. Regardless of the face to face or telehealth option, the same walking track will be used by each participant for each assessment to ensure consistency.

Gait variability (no stimulation)

时间窗: Baseline and 3-month re-assessment

Standard deviation of step times will be assessed by a wearable device (McRoberts). This will be measured for both face-to-face and telehealth options. For both baseline and re-assessment the no stimulation condition is used. For face to face, gait variability will be assessed using the middle 16m of 4 x 20m straight line walks. For telehealth, it may not be possible to find a 20m straight line walking track, in which case more laps will be required to get a total distance of at least 80 meters. Regardless of the face to face or telehealth option, the same walking track will be used by each participant for each assessment to ensure consistency.

次要结局

  • Freezing of gait(Baseline and post-intervention (3-months))
  • Exercise self-efficacy(Post-intervention (3-months))
  • Parkinson's disease health status(Baseline and post-intervention (3-months))
  • Physical activity level(Baseline and post-intervention (3-months))
  • Exercise adherence(Post-intervention (3-months))
  • Health service use(Post-intervention (3-months))
  • Rate of falling(Baseline and post-intervention (3-months))
  • Levodopa equivalency daily dosage(Baseline and post-intervention (3-months))
  • Health-related quality of life(Baseline and post-intervention (3-months))
  • Attitudes to fall related intervention(Post-intervention (3-months))
  • Activity of daily living(Baseline and post-intervention (3-months))
  • Postural balance and mobility(Baseline and post-intervention (3-months))
  • System usability(Post-intervention (3-months))
  • Lower extremity physical performance(Baseline and post-intervention (3-months))
  • Parkinson's disease symptoms(Baseline and post-intervention (3-months))
  • Inhibitory stepping ability(Baseline and post-intervention (3-months))
  • Polypharmacy(Baseline and post-intervention (3-months))
  • Physical activity enjoyment(Post-intervention (3-months))
  • Concern about falling(Baseline and post-intervention (3-months))
  • Simple stepping ability(Baseline (week 1) and post-intervention (7 weeks after randomisation).)
  • Complex stepping ability(Baseline and post-intervention (3-months))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验